FREE Account Opening + Lifetime Free Demat AMC*

Glenmark Life Sciences IPO

IPO Status: Closed [27th Jul 2021 to 29th Jul 2021]

Rated 4 stars Rated 4/5 by Team TopShareBrokers
Glenmark Life Sciences IPO Detail

Glenmark Lifesciences Limited, a leading Active Pharmaceutical Ingredients (API) manufacturer IPO of ₹ 1513.60 Cr opens on 27 July and closes on 29 July. The face value per share is Rs. 2, and the price band is fixed at Rs. 695-720. The floor price is 347.50 times and cap price is 360 times the face value. The lot size of the IPO is 20 shares. Stay tuned with us to know the opening and closing dates, price band, IPO lot size, and more.

Glenmark Life Sciences IPO Details

IPO Issue Opening Date: 27th Jul 2021
IPO Issue Closing Date: 29th Jul 2021
IPO Issue Price: ₹695-720 Per Share
IPO Listing At: BSE, NSE
Retail Quota: 50.23%
IPO Issue Type: Book Build Issue
IPO Issue Size: ₹1513.60 Cr
Offer for Sale: ₹453.60 Cr
Fresh Issue: ₹1060 Cr.
Face Value: ₹2 Per Equity Share
IPO Discount: NA
Promoter Holding Pre IPO: 100%
Promoter Holding Post IPO: 82.84%
Allotment Status: Allotment Status
BSE Code: 543322


Glenmark Life Sciences IPO Important Dates

In this section we have covered all important dates related to Glenmark Life Sciences IPO. Dates are updated as they are announced. The most noted dates are IPO start date and IPO end date, which one should use to participate in IPO.

Glenmark Life Sciences IPO important dates
IPO Activity Date
Basis of Allotment Date* 3rd Aug 2021
Refunds Initiation* 4th Aug 2021
Credit of Shares to Demat* 5th Aug 2021
IPO Listing Date* 6th Aug 2021

* - Tentative Dates

Glenmark Life Sciences IPO Lots

IPO Activity Date
Issue Price ₹695-720
Market Lot: 20 Shares
1 Lot Amount: ₹14400
Min Small HNI Lots(2-10 Lakh): 280 shares(14 lots)
Min Big HNI Lots(10+ Lakh):
  • Ranked #1 Broker in India(5*)
  • Get 100% Free Delivery Trading
  • Risk Free Account Opening
  • About Company - Glenmark Life Sciences

    Glenmark Life Sciences Limited has established strong footprint in Active Pharmaceutical Ingredients manufacturing. The company manufactures high-quality APIS for different diseases like cardiovascular disease, central nervous system disease, pain management, diabetes, gastrointestinal disorders, anti-infectives, and others. It operates in business verticals; Generic APIs (Generic and Complex) and CDMO (Contract Development and Manufacturing operations) to serve specialty pharmaceutical companies.

    Glenmark sells its products in India as well as other countries like Europe, Japan, Latin America, North America, etc. It has 4 manufacturing plants; 2 are in Gujarat and 2 are in Maharashtra. As of December 31, 2020, the manufacturing facilities have an aggregate installed capacity of 728.8 KL.

    Glenmark Life Sciences IPO Strengths

    • Leading player in high-value, non-commoditized APIs in Chronic therapeutic areas.
    • Quality-focused manufacturing with R&D infrastructure.
    • Experienced management with a proven track record.
    • International market presence.
    Incorporation Sector IPO Issue Size Website
    2011 Pharmaceutical ₹1513.60 Cr

    Glenmark Life Sciences IPO Objective

    • To pay purchase consideration to promoter for spin-off the API business from promoter to Glenmark Life Sciences Limited.
    • Finance capital expenditure requirements.
    • Meet general corporate purpose.

    Request call back from Zerodha

    Glenmark Life Sciences IPO Live Subscription (NSE + BSE)

    The table below is live update of IPO bidding details from NSE and BSE.

    • Qualified Institutional Buyers: 4,242,379 Shares
    • Non-Institutional Investors: 3,232,770 Shares
    • Retail Individual Investor: 7,543,130 Shares
    IPO Bidding Live Updates from BSE + NSE
    Day QIBNIIRIITotal
     # of Shares Offered4,242,379 (28.25%)3,232,770 (21.53%)7,543,130 (50.23%)15,018,279
    127th Jul 2021 17:020.00x0.86x5.17x2.78x
    228th Jul 2021 17:031.38x3.39x9.28x5.78x
    329th Jul 2021 17:0336.97x122.54x14.63x44.17x

    Glenmark Life Sciences Financials for past 3 Years

    Past performance and financial results of Glenmark Life Sciences.

    Glenmark Life Sciences financial
    Glenmark Life Sciences Limited Financials 31-Mar-2021 31-Mar-2020 31-Mar-2019
    Total Assets ₹1,997.08 Cr ₹1,725.60 Cr ₹1,475.40 Cr
    Total Income ₹1,885.98 Cr ₹1,549.30 Cr ₹886.87 Cr
    Net Profit/Loss ₹351.58 Cr ₹313.10 Cr ₹195.59 Cr

    Company Address

    Glenmark Life Sciences Limited
    Plot No. 170-172, Chandramouli Industrial Estate,
    Mohol Bazarpeth, Solapur,Maharashtra- 413 213
    Phone: +91 2189 234456/ +91 2189
    Email: [email protected]

    Glenmark Life Sciences IPO Registrar

    KFintech Private Limited
    KFintech, Tower-B, Plot No 31 & 32,
    Financial District, Nanakramguda, Gachibowli,
    Hyderabad, Telangana India - 500 032.
    Phone: 04067162222, 04079611000
    Email: [email protected]

    Glenmark Life Sciences IPO Lead Manager

    1. Kotak Mahindra Capital Company Limited
    2. SBI Capital Markets Limited
    3. BoA Merrill Lynch
    4. DAM Capital Advisors Ltd (Formerly IDFC Securities Ltd)
    5. BOB Capital Markets Limited
    6. Goldman Sachs (India) Securities Private Limited
    Glenmark Life Sciences IPO Important dates - Issue Open Date, close Date, IPO Listing Date. IPO Details - Offer Size, Issue Size, Type of IPO, Issue Price, Market Lot, BSE Cd, NSE Cd, IPO Listing date. What is the issue open date and close date for Glenmark Life Sciences? Should I apply in Glenmark Life Sciences IPO?

    Last Updated on 2021-09-27T10:41:33+00:00

    User Reviews

    7. Rajesh Jul 28 2021 11:41:50 AM Reply
    Kotak bank and Union Bank se ASBA k through kitni application apply kar sakte hain..
    7.1. CA Sachin Jain Jul 28 2021 11:43:08 AM
    Kotak and Union Bank ASBA IPO Application - 1 from Each Bank Account.
    Only SBI, Axis, PNB allow up to 5 application from one bank account.
    6. Vignesh A Jul 21 2021 08:25:20 AM Reply
    GMP 220
    5. Shubham Yashwant kale Jul 03 2021 10:56:06 PM Reply
    Glenmark Life Sciences IPO expected listing gain.
    4. Chebrolu Venkata Ramarao Jul 03 2021 10:56:06 PM Reply
    Please confirm Glenmark Life Sciences IPO GMP (grey market premium) and kostak.
    3. Vijay kumar chavan Jul 03 2021 10:56:06 PM Reply
    Glenmark Life Sciences IPO good or bad.
    2. Chinnathambi Jul 03 2021 10:56:06 PM Reply
    Glenmark Life Sciences IPO whether to invest or not.
    1. Mhd Anshar Jul 03 2021 10:56:06 PM Reply
    Glenmark Life Sciences IPO - CRISIL Rating, Apply or not?.